| 000 | 05218nam a22006495i 4500 | ||
|---|---|---|---|
| 001 | 978-981-97-4288-2 | ||
| 003 | DE-He213 | ||
| 005 | 20250516160119.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 240812s2024 si | s |||| 0|eng d | ||
| 020 |
_a9789819742882 _9978-981-97-4288-2 |
||
| 050 | 4 | _aQH521 | |
| 050 | 4 | _aQD415-436 | |
| 072 | 7 |
_aPSB _2bicssc |
|
| 072 | 7 |
_aMFGM _2bicssc |
|
| 072 | 7 |
_aSCI013040 _2bisacsh |
|
| 072 | 7 |
_aPSB _2thema |
|
| 072 | 7 |
_aMFGM _2thema |
|
| 082 | 0 | 4 |
_a572.4 _223 |
| 245 | 1 | 0 |
_aAltered Metabolism: A Major Contributor of Comorbidities in Neurodegenerative Diseases _h[electronic resource] / _cedited by Namita Agrawal. |
| 250 | _a1st ed. 2024. | ||
| 264 | 1 |
_aSingapore : _bSpringer Nature Singapore : _bImprint: Springer, _c2024. |
|
| 300 |
_aXIII, 438 p. 60 illus., 43 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _aChapter 1: An Overview of Neurodegenerative Disorders -- Chapter 2: Mechanism underlying major neurodegenerative disorders -- Chapter 3: Involvement of metabolic paradigm in progression of neurodegenerative diseases -- Chapter 4: Glial cell metabolism and neurodegenerative diseases: The current perspective -- Chapter 5: Altered glucose homeostasis in neurological disorders -- Chapter 6: Lipid Metabolism: Key Determinant in Neurodegenerative Diseases -- Chapter 7 - Dysregulated peripheral metabolism in neurodegenerative disorders -- Chapter 8- Protein Metabolism: Critical factors implicated in neurodegenerative diseases -- Chapter 9 - Altered RNA metabolism in neurodegenerative disorders -- Chapter 10: Unveiling RNA dysfunction: A key player in neurodegeneration -- Chapter 11: Emerging Relationship between the Gut Microbiota and Neurodegenerative Disorders -- Chapter 12- Signaling Pathways in Neurodegenerative diseases -- Chapter 13: An overview of imaging techniques for diagnosis of debilitating neurodegenerative diseases -- Chapter 14: Novel Metabolic Biomarkers and Therapeutic Strategies in Neurodegenerative Diseases -- Chapter 15: Phytochemicals: Promising alternatives for metabolic regulation in neurodegenerative diseases. | |
| 520 | _aThis book presents a systematic and extensive understanding about metabolic alterations affecting multiple aspects of different neurodegenerative diseases (NDDs), such as Alzheimer's, Parkinson's, Huntington's disease, SCAs, SBMA, DRPLA, ALS, Freidrich Ataxia etc. The book also illustrates cellular and molecular mechanisms behind the key neurodegenerative diseases and further expands on concept of unique and developing biomarkers associated with the onset and progression of NDDs. Additionally, it elaborates on the concept of latest imaging tools to monitor state of NDDs and accordingly develop therapeutic approaches entailing phytochemicals in the management of metabolic alterations associated with NDDs that ultimately suppresses course of devastating NDDs. The book aids to improve the overall understanding about the NDD and involvement of metabolic disorder as a major factor for indisposition of the disease. Therefore, suggesting that targetting metabolic variations by phytochemicals can combat NDD related symptoms for the betterment of impacted patients. While introducing cellular and molecular mechanisms and the treatment regimen under the umbrella of metabolism in several NDDs, the book covers major aspects of understanding the metabolic basis of NDDs, its implications, and treatment. This will inflate the readers' understanding about this particular area and guide those working in this domain, be it a researcher or clinicians,to choose or design effective therapeutic strategies to curb metabolic alterations linked with these disorders. This book will not only contribute towards improving the overall state of the challenged individuals but will also bring new hope towards improving the quality of lives of affected patients. | ||
| 541 |
_fUABC ; _cPerpetuidad |
||
| 650 | 0 | _aMetabolism. | |
| 650 | 0 |
_aNervous system _xDiseases. |
|
| 650 | 0 | _aTherapeutics. | |
| 650 | 0 | _aInternal medicine. | |
| 650 | 0 |
_aMedicine _xResearch. |
|
| 650 | 0 |
_aBiology _xResearch. |
|
| 650 | 0 | _aNatural products. | |
| 650 | 1 | 4 | _aMetabolism. |
| 650 | 2 | 4 | _aNeurological Disorders. |
| 650 | 2 | 4 | _aTherapeutics. |
| 650 | 2 | 4 | _aInternal Medicine. |
| 650 | 2 | 4 | _aBiomedical Research. |
| 650 | 2 | 4 | _aNatural Products. |
| 700 | 1 |
_aAgrawal, Namita. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9789819742875 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789819742899 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789819742905 |
| 856 | 4 | 0 |
_zLibro electrónico _uhttp://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-981-97-4288-2 |
| 912 | _aZDB-2-SBL | ||
| 912 | _aZDB-2-SXB | ||
| 942 | _cLIBRO_ELEC | ||
| 999 |
_c276007 _d276006 |
||